Latest News

2025.06.13
Breakthrough in Precision Kidney Assessment: Leadgene Biomedical's Indoxyl Sulfate ELISA Kit Receives IVD Approval in Singapore
Leadgene's IVD solution for kidney function assessment has officially received IVD approval from Singapore’s Health Sciences Authority (HSA). This achievement marks another important milestone in expanding Leadgene Biomedical’s global footprint and underscores our ongoing commitment to delivering high-quality, reliable solutions for chronic kidney disease.
2025.05.27
Leadgene Biomedical Receives Singapore IVD Approval
Leadgene Biomedical Achieves Regulatory Milestone with Singapore Health Sciences Authority Approval
2025.05.20
Biotech Talent Shortage Threatens Taiwan’s Industry Transformation: Cross-Disciplinary Experts Key to Unlocking Innovation
Biotech Talent Shortage Threatens Taiwan’s Industry Transformation: Cross-Disciplinary Experts Key to Unlocking Innovation
1
/
3
2025.04.24

Leadgene Biomedical Develops Next-Generation Platforms to Strengthen CDMO Integration in Global Markets
2025.04.22

Developing Next Generation Diagnostic Biological Reagents
2025.03.14

Is Your Kidney Health at Risk? Early Screening and Treatment Are Crucial for High-Risk Groups
2025.02.21

New Distributor Announcement - EZchemtech Inc.
2025.01.24

Chronic Kidney Disease Emerges as a Silent Killer – Experts Stress the Need for Accurate Diagnostics
2025.01.14

Successful Registration of Key Products in US FDA DMF
2025.01.02

Leadgene Biomedical Completes 100% Acquisition of SIDSCO to Drive Business Integration and Maximize Synergy
2024.12.30

Leadgene Indoxyl Sulfate (IS) ELISA Kit Awarded the 2024 Symbol of National Quality (SNQ)
2024.11.15

Leadgene Biomedical at the 2024 Healthcare+ Expo Taiwan!
2024.10.18

Meet us at MEDICA Düsseldorf 2024!
2024.09.09

Meet Us at MEDICAL FAIR ASIA 2024!
2024.08.16

Leadgene Biomedical Expands in Northern Taiwan with New Innovation & Research Center and CLD Center